COAG - CIK 0002114044
The table below shows Hemab Therapeutics Holdings, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 |
|---|---|
| Cash & equivalents | $49.86M |
| Short-term investments | $113.67M |
| Receivables | - |
| Inventory | - |
| Total current assets | $169.43M |
| Property, plant & equipment | $648.00K |
| Goodwill | - |
| Total assets | $175.26M |
| Accounts payable | $5.68M |
| Total current liabilities | $13.19M |
| Long-term debt | - |
| Total liabilities | $13.71M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Retained earnings |
| -$204.54M |
| Total equity | -$198.62M |